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Assembly and structure of Lys33-linked polyubiquitin reveals distinct
conformations
Yosua Adi Kristariyanto*, Soo-Youn Choi*, Syed Arif Abdul Rehman*, Maria Stella Ritorto*, David G Campbell*, Nicholas A
Morrice*1, Rachel Toth* and Yogesh Kulathu*2
*MRC Protein Phosphorylation and Ubiquitylation Unit, College of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, U.K.
Ubiquitylation regulates a multitude of biological processes
and this versatility stems from the ability of ubiquitin (Ub) to
form topologically different polymers of eight different linkage
types. Whereas some linkages have been studied in detail,
other linkage types including Lys33-linked polyUb are poorly
understood. In the present study, we identify an enzymatic system
for the large-scale assembly of Lys33 chains by combining the
HECT (homologous to the E6–AP C-terminus) E3 ligase AREL1
(apoptosis-resistant E3 Ub protein ligase 1) with linkage selective
deubiquitinases (DUBs). Moreover, this first characterization
of the chain selectivity of AREL1 indicates its preference for
assembling Lys33- and Lys11-linked Ub chains. Intriguingly, the
crystal structure of Lys33-linked diUb reveals that it adopts a
compact conformation very similar to that observed for Lys11-
linked diUb. In contrast, crystallographic analysis of Lys33-linked
triUb reveals a more extended conformation. These two distinct
conformational states of Lys33-linked polyUb may be selectively
recognized by Ub-binding domains (UBD) and enzymes of the
Ub system. Importantly, our work provides a method to assemble
Lys33-linked polyUb that will allow further characterization of
this atypical chain type.
Key words: deubiquitinase, homologous to the E6–AP C-terminus
(HECT) E3 ligase, polyubiquitin, ubiquitin linkage.
INTRODUCTION
Ubiquitylation is a reversible post-translational modification
(PTM) that regulates many cellular processes, including protein
degradation, endocytosis, DNA repair and immune response [1].
Addition of ubiquitin (Ub) to a substrate lysine involves a three-
step enzymatic cascade involving Ub-activating enzyme (E1),
Ub-conjugating enzymes (E2) and Ub-ligating enzymes (E3)
[2]. E3 ligases fall into three main classes depending on their
mechanism of Ub transfer to substrate. RING (really interesting
new gene) ligases transfer Ub directly from the E2 on to substrate
whereas HECT (homologous to the E6–AP C-terminus) ligases
form a thioester intermediate with Ub before transfer on to
substrate lysine [3,4]. RBR (RING-between-RING) ligases form
the third class and employ a hybrid mechanism for catalysing Ub
transfer [5].
PolyUb chains of eight different linkage types can be formed
since the seven lysine residues (Lys6, Lys11, Lys27, Lys29, Lys33,
Lys48 and Lys63) and N-terminal Met1 residue in Ub can
themselves accept another molecule of Ub [6]. PolyUb of some
linkage types have been structurally characterized and these reveal
distinct conformations for different linkages [7]. Crystal structures
and solution studies using NMR reveal closed conformations
for Lys6-, Lys11- and Lys48-linked diUb as a result of extensive
interactions between the Ub moieties [8–12]. In contrast,
Lys63- and Met1-linked diUb adopt extended conformations
that lack intermoiety interactions [13]. Interestingly, alternate
conformations have been observed for some linkage types,
highlighting the flexible nature of polyUb [14,15].
The topologically distinct polyUb linkages are recognized
by Ub-binding domain (UBD)-containing proteins to couple
ubiquitylation to diverse cellular responses [16]. For instance
Lys48-linked polyUb target proteins for proteasomal degradation,
whereas Lys63- and Met1-linked polyUb chains have non-
degradative roles in DNA damage response and NF-κB (nuclear
factor kappa-light-chain-enhancer of activated B-cells) signalling
[1,17]. For the remaining linkage types, little is known about their
precise cellular function.
Lys33 chains may not be linked to proteasomal degradation,
as the amounts of Lys33 linkages do not increase following
proteasome inhibition [18]. Further, several studies show that
Lys33 chains have non-degradative functions. T-cell antigen
receptor (TCR) activation is negatively regulated in a proteolysis
independent manner by Lys33-linked polyUb, when the RING
and HECT E3 ligases, Cbl-b (Casitas B-lineage lymphoma b)
and Itch respectively modify the zeta-subunit of the TCR with
this Ub chain type [19]. Lys33-linkages are also reported to
negatively regulate activity of AMPK (AMP-activated protein
kinase)-related protein kinases in a non-degradative manner
[20]. This linkage type has recently been linked to protein
anterograde transport from the trans-Golgi network (TGN), where
Lys33-linked polyubiquitylation of coronin-7 (Crn7), an F-actin
regulator, facilitates its targeting to the TGN, which promotes F-
actin assembly at TGN and contributes to post-Golgi trafficking
Abbreviations: AREL1, apoptosis-resistant E3 ubiquitin protein ligase 1; ASU, asymmetric unit; Crn7, coronin-7; DUB, deubiquitinase; HECT, homologous
to the E6–AP C-terminus; pRM, parallel reaction monitoring; PTM, post-translational modification; RBR, RING-between-RING; RING, really interesting new
gene; TCR, T-cell antigen receptor; Ub, ubiquitin; UBD, ubiquitin-binding domain.
1 Present address: AB Sciex UK Limited, Warrington, Cheshire WA1 1RX, U.K.
2 To whom correspondence should be addressed (email ykulathu@dundee.ac.uk).
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[21]. Interestingly, Lys33-ubiquitylated Crn7 is recognized by
the UBDs of the clathrin adaptor protein Epsin15 to result in
translocation of Crn7 to the TGN.
Being a reversible PTM, ubiquitylation is regulated by
deubiquitinases (DUBs) that hydrolyse isopeptide bonds between
two Ub moieties or between Ub and the targeted protein
[6,22]. The DUB TRABID (TRAF-binding domain-containing
protein) was recently identified to preferentially hydrolyse Lys29-
and Lys33-linkages [8,23,24]. Whereas TRABID was shown
to regulate Wnt signalling, it is not clear if Lys33-linked
polyubiquitylation is involved [25]. Whereas these studies point
to non-proteolytic roles for Lys33 linkages in several cellular
processes, we have a poor understanding of the ligases that can
assemble Lys33 linkages, the specific signals in response to which
they are made, how they are decoded and disassembled.
In the present study, we focused on identifying ligases
capable of assembling Lys33 chains for biochemical and structural
characterization. By screening a panel of HECT E3 ligases we
identified the uncharacterized ligase AREL1 (apoptosis-resistant
E3 Ub protein ligase 1; also known as KIAA0317) to assemble
Lys33 linkages along with other linkages. We then used linkage-
selective DUBs to remove these additional linkages assembled
by AREL1 to obtain pure Lys33 chains. The enzymatic system
we established allowed us to assemble large quantities of Lys33-
linked polyUb, thus enabling structural analysis of this atypical
chain. We report the first crystal structures of Lys33-linked diUb
and triUb, which reveal distinct conformations.
MATERIALS AND METHODS
cDNA and antibody
All cDNA constructs used in the present study were generated
by the DNA cloning team, Division of Signal Transduction
Therapy, Medical Research Council Protein Phosphorylation
and Ubiquitylation Unit, University of Dundee United Kingdom
(Supplementary Table S1). Recombinant proteins and plasmids
generated for the present study are available from our
reagents website (https://mrcppureagents.dundee.ac.uk/). Anti-
Ub antibody was purchased from SIGMA (U5379).
Protein expression and purification
Recombinant GST-fusion proteins were expressed in BL21
Escherichia coli cells. Cultures were grown in 2xTY media to
D600 of 0.6–0.8 and the protein expression was induced by adding
300 μM IPTG and further incubation at 16 ◦C overnight. Cells
were lysed by sonication in lysis buffer [50 mM Tris/HCl, pH 7.5,
300 mM NaCl, 10% glycerol, 0.075% 2-mercaptoethanol, 1 mM
benzamidine, 1 mM PMSF and complete protease inhibitor
cocktail (Roche)]. Bacterial lysate was clarified by centrifugation
at 30000 g for 30 min and incubated subsequently with
Glutathione Sepharose 4B resin (GE Healthcare) for 2 h at 4 ◦C.
Resins were washed with high salt buffer (250 mM Tris, pH 7.5,
500 mM NaCl and 5 mM DTT) and low salt buffer (25 mM Tris,
pH 7.5, 150 mM NaCl, 10% glycerol and 1 mM DTT). Purified
proteins were eluted in low salt buffer supplemented by 30 mM
glutathione or cleaved off from the GST-tag by incubating the
beads with C3 protease overnight at 4 ◦C.
Ubiquitylation assays
Analytical assays were carried out in 20 μl of reaction mixtures
containing 250 nM UBE1 (Ub-activating enzyme E1), 2.25 μM
UBE2 (Ub-conjugating enzyme E2) (UBE2D1, D2, D3 or
L3), 1.56 μM HECT E3 (ITCH, AREL1, SMURF1 (SMAD
ubiquitylation regulatory factor 1), SMURF2, UBE3C, HECW1
(HECT, C2 and WW domain-containing protein 1), HUWE1
(HECT, UBA and WWE domain-containing protein 1), WWP1
(WW domain-containing protein 1) or WWP2), 57 μM Ub,
10 mM ATP, 50 mM Tris/HCl (pH 7.5), 10 mM MgCl2 and
0.6 mM DTT for 3 h at 30 ◦C. The reaction was quenched by
addition of LDS (lithium dodecyl sulphate) sample buffer (Life
Technology), resolved by SDS/PAGE on 4%–12% gradient gels
and subjected to Western blot analysis using anti-Ub antibody.
Where indicated, after 3 h reaction, a final concentration of
20 μM Cezanne EK, 5 μM OTUB1 (OTU domain-containing
ubiquitin aldehyde-binding protein 1), 5 μM TRABID and 5 mM
DTT was added to the ubiquitylation reaction and incubated
further for 2 h at 30 ◦C.
Lys33-linked polyUb assembly and purification
Large-scale Lys33-linked polyUb chains assembly was carried
out in 1.5 ml of reaction volume with 25 mg of Ub (Sigma),
500 nM UBE1, 9 μM UBE2D1, 6.3 μM AREL1, 10 mM ATP,
50 mM Tris/HCl (pH 7.5), 10 mM MgCl2 and 0.6 mM DTT at
30 ◦C for 6 h. To remove contaminating linkages, 20 μM Cezanne
E287K/E288K (Cezanne EK), 5 μM OTUB1 and 5 mM DTT were
added in to the assembly reaction and incubated further at 30 ◦C
overnight. The reaction mixture was diluted to a total volume of
50 ml of 50 mM sodium acetate (pH 4.5). Lys33 chains of defined
lengths were purified by cation exchange using a Resource S 6 ml
column (GE Healthcare), equilibrated in buffer A (50 mM sodium
acetate, pH 4.5) and eluted in a gradient with buffer B (50 mM
sodium acetate, pH 4.5, 1 M NaCl).
Parallel reaction monitoring MS analysis
PolyUb chains were digested with trypsin and analysed on an
LTQ-Velos mass spectrometer (Thermo) fitted with an Easy-Spray
Source (Thermo) and utilizing a Dionex RSLC HPLC system.
Standard diUb chains were purchased from Boston Biochemicals
and a synthetic peptide AK(GG)IQDK representing the tryptic Ub
K29 linkage was purchased from Pepceuticals. Digests (prepared
in 0.1% TFA (trifluoroacetic acid)/water) were concentrated on
a 20 × 0.1 mm nanotrap column (Thermo) equilibrated in 0.1%
TFA/water (10 μl/min) and washed with 10 μl of the same buffer.
The samples were loaded and washed in TFA buffers, as the
trap column in the presence of formic acid did not retain the
tryptic peptide containing the Lys29 linkage. Peptides were then
separated on a 150 × 0.075 mm PepMap C18, 3 μm Easy-Spray
column (Thermo) equilibrated with 2% acetonitrile/0.1% formic
acid/water at 300 nl/min, employing a stepped gradient of buffer B
(80% acetonitrile/0.1% formic acid/water) as follows: 0–14 min
= 1%–30% B, 14–15 min = 30%–80% B, 15–20 min = 80%
B. LC–MS data was acquired in data-independent mode with one
full scan (m/z = 350–1800) followed by eight product ion scans
as described below. Parameters used: Easy-Spray column voltage
was 1.9 kV; isolation width was set to 1 Da; normalized collision
energy was 35, and the activation time was 10 ms. The ion
current for the daughter ions was summed using Xcalibur software
(Thermo) for each precursor mass analysed (Supplementary Table
S2). The resultant summed intensities provide the y-axis values
for Figure 1(B) and Supplementary Figure S2. This method was
more specific than solely using the extracted ion current for the
precursor mass for each Ub chain peptide.
c© The Authors Journal compilation c© 2015 Biochemical Society
Assembly and structure of Lys33 polyubiquitin 347
B
A
10
15
20
25
37
50
75
100
150
250
kDa
D1D2D3 L3 D1D2D3 L3
ITCH AREL1
D1 D2D3 L3
SMURF1
D1D2D3 L3
SMURF2
D1D2 D3 L3
UBE3C
D1D2D3 L3
HUWE1HECT E3:
UBE2: D1D2D3 L3
WWP1
D1D2D3 L3
WWP2
D1D2D3 L3
UBE3B
D1D2D3 L3
KIAA1333
D1D2D3 L3
HECW1
D1D2D3 L3
EDD1
IB: anti-ubiqutin
Figure 1 Screening of HECT E3 ligases to identify enzymes that assemble Lys33-linked polyUb
(A) Ubiquitylation assays of HECT E3 ligases in the presence of UBE1, Ub and different E2 enzymes: UBE2D1, UBE2D2, UBE2D3 and UBE2L3. (B) Ubiquitylated products generated by HECT E3
ligases with the optimal E2 were analysed by pRM LC–MS/MS for the abundance of Ub linkages as described in ‘Materials and Methods’ (Supplementary Figure S1B). Each Ub linkage assembled
by the HECT E3 ligases was plotted as a bar graph where the y-axes are summed ion current values for the relevant daughter ions of each precursor mass analysed (Supplementary Table S2). No
signal was observed for Met1 and Lys27 linkages for any of the ligases tested.
Crystallization and structure determination
Purified Lys33-linked diUb chains were crystalized at 9 mg/ml
in mother liquor containing 200 mM lithium sulfate, 100 mM
sodium acetate (pH 4.5) and 50% PEG400. Further, diffraction
quality of the crystal was improved using seeding technique in
the presence of 200 mM potassium iodide and 20% PEG3350
in addition to the mother liquor as mentioned above. Purified
Lys33-linked triUb chains were crystalized at 8 mg/ml in mother
liquor containing 20 mM sodium/potassium phosphate, 100 mM
Bis Tris propane (pH 7.5) and 20% PEG3350. Single crystals
obtained from Lys33-linked diUb and triUb chains were cryo-
protected in the mother liquor containing 20% and 30% ethylene
glycol respectively. Diffraction data were collected at ESRF
(European Synchrotron Radiation Facility) beam line ID29. All
data were processed as in described in ‘Supplementary Materials
and Methods’. Co-ordinates and structure factors for the refined
Lys33 diUb and triUb have been deposited in the Protein Data Bank
(PDB, www.rcsb.org) under the accession code 4XYZ and 4Y1H
respectively.
RESULTS AND DISCUSSION
Assembly of Lys33-linked polyubiquitin
Lys11, Lys48 and Lys63 chains can be assembled in vitro
using E2 enzymes, whereas Lys6- and Met1-linked polyUb
can be assembled by HECT and RBR E3 ligases respectively
[9,11,26,27]. Unlike RING E3 ligases, in which the linkage
specificity is largely determined by the E2, polyUb assembly by
HECT E3 ligases is independent of the inherent linkage preference
of the E2 [7]. Therefore, we screened a panel of HECT E3s with
the aim of identifying HECT E3 ligases capable of assembling
c© The Authors Journal compilation c© 2015 Biochemical Society
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Lys33 linkages. Either the full-length or the catalytic domains of
16 HECT E3 ligases were expressed as GST fusion proteins in
E. coli. We obtained soluble expression for 12 of them, which
were then purified to near homogeneity (Supplementary Figure
S1A). We next determined the preferred E2 of a given HECT
by comparing ubiquitylation products generated by the HECT
in reactions performed with each of the following E2 enzymes:
UBE2D1, UBE2D2, UBE2D3 or UBE2L3 (Figure 1A). Since
HECT family ligases interact with UBE2L3 (UbcH7) and the
UBE2D (UbcH5) subfamily of E2s, these E2 enzymes were
selected for the screens [28,29]. With the exception of UBE3B,
KIAA1333 and EDD1, all the tested HECT E3 ligases assembled
polyUb chains (Figure 1A). Further, most of the HECTs work
with UBE2D family members (Figure 1A). In this screen we
found that AREL1 assembled shorter polyUb chains compared
with the rest of HECT E3s. AREL1 might have slower kinetics
as upon prolonged reaction time AREL1 also assembled longer
chains (Supplementary Figure S1C). On the other hand, UBE3B,
KIAA1333 and EDD1 failed to assemble polyUb chains, even
after 6 h incubation (Figure 1A; Supplementary Figure S1C).
Next, we utilized MS to characterize the Ub linkages assembled
by the different HECT E3 ligases (Supplementary Figure S1B).
We analysed the products of the different HECT-mediated
ubiquitylation reactions by parallel reaction monitoring (pRM)
LC–MS/MS, a method that exclusively monitors the abundance of
the daughter ions belonging to peptides derived from Ub linkages
(Figure 1B) [30]. In accordance with previously published
observations, we found that UBE3C assembles Lys29 and Lys48
linkages (Figure 1B) [31]. Further, most of the HECT E3s tested
assembled Lys48 and Lys63 linkages similar to what had been
observed previously [29,32]. Lys6 linkages are assembled mostly
by HUWE1 and Lys11 linkages are assembled by AREL1 and to
some extent by HECW1 and HUWE1 (Figure 1B). Interestingly,
our screen of HECT E3 ligases identified AREL1 as capable of
assembling Lys33 linkages (Figure 1B).
It is important to note that these in vitro screens assess polyUb
linkages assembled by the HECT ligase in the absence of its
bona fide substrate. In the presence of physiological substrates,
these HECT E3s might assemble different linkages, preferring
one linkage type over others. For example, Itch, which assembles
Lys63 linkages in vitro (Figure 1B), has been reported to modify
its substrates with Lys29 or Lys48 linkages [33]. Additionally, Itch
works co-operatively with RING E3 Cbl-b to ubiquitylate TCR-
ζ with Lys33 linkages. This suggests that additional factors may
influence polyUb assembly by HECT E3 ligases.
Whereas AREL1 makes Lys33 chains, it also assembles Lys11
and Lys48 linkages (Figures 1B and 2A). To obtain pure Lys33-
linked polyUb, the other linkages assembled by AREL1 have
to be removed, for which linkage-selective DUBs are required.
Cezanne mainly hydrolyses Lys11 linkages, whereas OTUB1
only cleaves Lys48 linkages [24]. We used a mutant version of
Cezanne (Cezanne EK) that hydrolyses Lys6, Lys11, Lys48 and
Lys63 linkages (Supplementary Figure S2). When Cezanne EK
and OTUB1 were included in the assembly reaction, the end
product was enriched in free polyUb chains and almost 90%
of the input Ub was converted into unanchored or free polyUb
chains (Figure 2B). In order to confirm the linkage type of the
resulting polyUb chains, we performed a linkage type analysis
using Ub mutants containing lysine-to-arginine substitutions. In
the presence of Cezanne EK and OTUB1, free polyUb chain
formation was not impaired with K6R, K11R, K27R, K29R,
K48R or K63R mutants (Figure 2C). In contrast, formation
of polyUb chains was significantly reduced with the K33R
mutant, suggesting that this method generates polyUb chains that
are Lys33 linked (Figure 2C). Moreover, when incubated with
Table 1 Data collection and refinement statistics
Lys33-linked diUb Lys33-linked triUb
Data collection
Wavelength (A˚) 0.999 0.976
Resolution range (A˚) 33.83 to 1.65 31.42 to 1.40
(1.71 to 1.65) (1.45 to 1.40)
Space group P 21 P 21 21 21
Unit cell a, b, c (A˚) 29.48, 57.02, 33.98 28.94, 41.83, 47.60
α, β , γ (◦) 90.00, 95.45, 90.00 90.00, 90.00, 90.00
Total reflections 58324 (5866) 74848 (7266)
Unique reflections 13474 (1348) 11652 (1127)
Multiplicity 4.3 (4.4) 6.4 (6.4)
Completeness (%) 99.40 (99.04) 98.06 (97.16)
I/σ I 10.55 (4.20) 18.51 (12.82)
Rmerge 0.1033 (0.2502) 0.0948 (0.1303)
CC1/2 0.99 (0.936) 0.99 (0.986)
Refinement
Number of atoms
Protein 1183 605
Ligand/ion 22 16
Water 99 36
Rwork/R free 0.165/0.214 0.158/0.194
RMSD
Bond lengths (A˚) 0.019 0.026
Bond angles (◦) 1.98 2.28
Average B-factor (A˚2) 12.59 18.04
The highest resolution shell is shown in parentheses.
the DUB TRABID that specifically hydrolyses Lys29 and Lys33
linkages [23], the assembled polyUb chains were cleaved down to
monoUb, confirming the presence of Lys33 linkages (Figure 2D).
Taken together, these results demonstrate that an Ub chain editing
complex made up of the enzymes AREL1, UBE2D1, Cezanne EK
and OTUB1 can be used to assemble Lys33-linked polyUb chains.
We next scaled up the assembly reactions to make a
large quantity of Lys33-linked chains. Using cation exchange
chromatography, we could separate Lys33-linked chains of defined
lengths containing 2–5 Ub moieties and the purity of Lys33-linked
diUb and triUb was confirmed by silver staining (Figures 2E
and 2F). pRM LC–MS/MS analyses of purified diUb and triUb
validated that the purified polyUb chains produced using this
approach only contained Lys33 linkages and other linkages were
not detected (Supplementary Figure S2B). Taken together, these
data reveal a robust and reproducible method for generating
milligram quantities of Lys33-linked polyUb.
Crystal structure of Lys33 diubiquitin
The topology of polyUb of different linkage types and potentially
the length of the polyUb chains determine specificity and outcome
of polyUb recognition. We therefore wanted to structurally
characterize Lys33-linked polyUb chains. We obtained crystals
of Lys33-linked diUb at 9 mg/ml and the crystals diffracted to
1.65 Å (1 Å = 0.1 nm) resolution. The structure was solved
by molecular replacement and refined to the statistics shown in
Table 1. The asymmetric unit (ASU) contains one Lys33-linked
diUb (Figure 3A). The flexible isopeptide linkage formed between
the C-terminus of the distal Ub and Lys33 of the proximal Ub is not
fully resolved in the electron density maps and no clear electron
density is present for Gly76.
Lys33-linked diUb adopts a symmetric compact conformation in
the crystal structure with extensive hydrophobic contacts between
the proximal and distal moieties. Ile36 patches of both proximal
and distal Ub moieties, which comprise Ile36, Leu71 and Leu73, are
c© The Authors Journal compilation c© 2015 Biochemical Society
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Figure 2 Assembly of Lys33-linked polyUb
(A) Ubiquitylation assays of AREL1 in the presence of UBE1, UBE2D1 and wild-type Ub or Ub mutants that have only one or no lysine residue. (B) Large-scale assembly of polyUb chains by
AREL1 in the presence of UBE1, UBE2D1 and Ub. The addition of DUBs, Cezanne EK and OTUB1, releases free polyUb chains. (C) Ubiquitylation assays of AREL1 in the presence of UBE1, UBE2D1
and wild-type Ub or lysine-to-arginine Ub mutants. DUBs, Cezanne EK and OTUB1, were added after 3 h of reaction. (D) Auto-ubiquitylation assays of AREL1 as in (A) with wild-type Ub. DUBs,
Cezanne EK, OTUB1 and TRABID, were added after 3 h reaction as indicated. (E) Purification of Lys33-linked chains of defined lengths by cation-exchange chromatography. (F) The Lys33-linked diUb
and triUb purified in (D) were visualized in silver-stained SDS gel.
present at the dimeric interface (Figure 3B). Further hydrophobic
contacts in this symmetric interface involve Leu8, Ile13 and Leu69
of both moieties (Figure 3B). Leu8 is part of a flexible loop in
Ub that spans the β1 and β2 strands (β1–β2 loop) and exhibits
different conformations in different Ub structures [34]. Depending
on the conformation of this loop, Leu8 is part of either the
Ile36 patch or the orthogonal hydrophobic patch centred on Ile44,
consisting of residues Ile44, Val70 and His68. In the observed Lys33
diUb structure, this loop is oriented towards Ile44 and is thus
part of the Ile44 patch (Figure 3C). In contrast, the β1–β2 loop
conformation in the distal Ub of Lys6 diUb makes Leu8 part of
the Ile36 patch (Figure 3C) [8].
In the compact conformation of Lys6 diUb, the interface is
made up of the extended Ile36 patch from the distal Ub and the
Ile44 patch of the proximal Ub (Figure 3D). In Lys48 diUb,
the interface is made up of Ile44 patches of both distal and proximal
Ub (Figure 3D). The compact conformation observed for Lys33
diUb is distinct from the compact conformations observed for
Lys6 and Lys48 diUb (Figure 3D) [8,9,12]. The Ile36 patches of
both distal and proximal Ub in Lys33-linked diUb are buried
and make up the interface, whereas the Ile44 patches form a
larger hydrophobic surface and are solvent exposed. Molecular
modelling approaches predict that Lys33-linked diUb exists in an
open conformation and cannot adopt a compact conformation due
to steric occlusion [35]. However, our crystal structure reveals that
Lys33-linked diUb can adopt a closed conformation. Intriguingly,
the closed conformation of Lys33 diUb is very similar to that
adopted by Lys11-linked diUb (Figure 3D) [10]. Despite the similar
conformations adopted by Lys11 and Lys33 linkages, DUBs can
still distinguish between the two linkage types highlighting the
remarkable selectivity present in the Ub system [24].
Crystal structure of Lys33 triubiquitin
The presence of a symmetric interface raises the question of
how chain extension can be achieved and what structure longer
Lys33 polyUb chains adopt. To address this question we purified
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Figure 3 Crystal structure of Lys33-linked diUb
(A) The crystal structure of Lys33 diUb in two orientations. (B) Lys33 diUb is shown in ribbon and the residues at the interface are shown in stick representation. (C) Leu8 residue of Lys33-linked diUb
contributes to Ile44 patch. Proximal Ub of Lys33 diUb and distal Ub of Lys33 diUb, Lys11 diUb (PDB 3NOB [10]) and Lys6 diUb (PDB 2XK5 [8]) were superposed with monoUb (PDB 1UBQ [41]) and
coloured light cyan. The position of Leu8 (red), Ile36 (green) and Ile44 (blue) are indicated. As reference, the Leu8 of monoUb is not coloured differently. (D) A semi-transparent surface, coloured blue
for Ile44 patch (Ile44, Leu8, His68 and Val70) and green for Ile36 patch (Ile36, Leu71 and Leu73) of diUb linked via Lys33, Lys6, Lys48 and Lys11 (PDB 2XK5, 3NOB, 1AAR [8,10,12]).
milligram quantities of Lys33-linked triUb for crystallization
studies. Lys33 triUb crystallized in a different space group with
unit cell dimensions different from that of Lys33 diUb crystals.
Diffraction data were obtained at 1.4 Å resolutions and the
structure solved by molecular replacement and refined to the final
statistics shown in Table 1. Although we crystallized triUb, the
ASU only contains one Ub molecule (Figures 4A and 4B, chain
B). In the crystal lattice, neighbouring Ub molecules complete
the trimer where the C-terminus of a symmetry-related molecule
(chain C) is close to Lys33 of chain B; and the C-terminus of chain
B is positioned close to Lys33 residue of chain A (Figure 4A). Clear
electron density is visible for the isopeptide linkage connecting
the Ub moieties via Lys33 (Supplementary Figure S3).
In contrast with the compact conformation adopted by
Lys33 diUb that involves extensive hydrophobic interactions
at its interface, Lys33-linked triUb adopts an open extended
conformation. The three Ub molecules of the trimer are arranged
in the same orientation forming a linear array, where there are no
interactions between the individual Ub moieties apart from the
isopeptide linkage (Figures 4A and 4B). When compared with
the compact diUb, the proximal Ub of Lys33-linked triUb is rotated
by almost 65◦ suggesting lack of rotational constraints between
individual Ub moieties (Figure 4C). Further, the hydrophobic
patches are exposed to solvent, where symmetric arrangement
positions the Ile44 hydrophobic patches on the same face of the
trimer and the Ile36 patches on another face (Figure 4D). This
extended conformation of Lys33 chains differs from the fully
extended conformations observed for Lys63 and Met1 diUb [13].
In the crystal structures of Lys63 and Met1 chains, the hydrophobic
patches alternate on opposite sides of the chain whereas they are
located on the same face in Lys33 chains (Figures 4D–4F).
Taken together, these results reveal two distinct conformations
of Lys33-linked Ub chains and the compact and extended
conformations observed are distinct from those of Lys6, Lys48,
Met1 and Lys63 chains (Supplementary Figure S4). It is to be noted
that the diUb structure was obtained from crystals grown at low pH
(pH 4.5) whereas the triUb structure was from crystals grown at
pH 7.5. This is in contrast with Lys48 chains that adopt a compact
conformation at physiological conditions and an open one at
low pH (pH 4.5) [36,37]. The lack of intermoiety interactions
in Lys33-linked triUb suggests that the relative orientations of
the Ub moieties may vary in solution, with our crystal structure
representing a snapshot of this dynamic process. Further studies
will be required to determine the preferred conformation of Lys33
chains in solution.
The topology of polyUb chains together with the relative
positioning and orientation of the hydrophobic patches are
factors that determine linkage selectivity in polyUb binding.
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(A) The crystal structure of Lys33-linked triUb. (B) Representative diagram of how a Ub moiety in an ASU is arranged into triUb (left) and how Ile44 and Ile36 patches are located in Lys33-linked
triUb (right) (C) Superposition of the distal Ub moieties (white) of Lys33-linked diUb and Lys33-linked triUb, shown in cartoon and surface representations. Hydrophobic patches are coloured as in
Figure 3D. Only two Ub moieties are shown for Lys33-linked triUb. In comparison with the proximal Ub of Lys33 diUb (teal), the proximal Ub of Lys33 triUb (orange) moves approximately 65◦ from to
the more open conformation. (D–F) A semi-transparent surface of Lys33 triUb (D), Met1 diUb (E) and Lys63 diUb (F) coloured as in Figure 3D (PDB 2W9N, 2JF5 [13]).
We have determined the structures of Lys33-linked diUb and
triUb that reveals compact and extended conformations with
distinct characteristics. It will be important to analyse how
UBDs and DUBs exploit the distinct features of Lys33-linked
polyUb to achieve linkage-selective recognition. The exposed
hydrophobic patches, the unique structural features and the
different conformations that can be adopted by Lys33-linked
polyUb are likely to be exploited by DUBs and UBDs. Further,
shorter Lys33 chains may have different conformations compared
with longer chains and this introduces an additional layer of
regulation where the length of the polyUb chain may determine
which UBD binds and thereby determining the outcome of
ubiquitylation.
AREL1 was recently identified as a novel anti-apoptotic E3
Ub ligase [38]. However, the Ub linkages assembled by AREL1
were not investigated. In our in vitro HECT E3 screen, we find
that AREL1 mainly assembles Lys33 and Lys11 polyUb chains
along with small amounts of Lys48 and Lys63 linkages. We
speculate that AREL1 assembles mixed and branched polyUb
chains containing different linkages. There is growing evidence
suggesting specialized roles for mixed and branched chains
[39,40]. Therefore, it will be important to address whether
AREL1 assembles heterotypic chains in cells and what its cellular
substrates are. Alternatively, AREL1 may be present in complex
with DUBs that could promote ubiquitylation of substrates with
homotypic Lys33 chains. Indeed studying the functional role
of AREL1 may reveal insights into the biological roles of
Lys33-linked polyubiquitylation. Importantly, we provide the first
description of an enzymatic system for the large-scale assembly
of Lys33-linked polyUb, which will pave the way for future
studies.
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